RPG Life Sciences reports Q3 FY26 revenue of Rs 180.0 cr, up 4.2% YoY, with EBITDA margin at 24.0%; 9M FY26 revenue up 4.0% and Domestic Formulations growth outpacing IPM.
AI Assistant
RPG Life Sciences Ltd
2026
Announcement
Find Answers
Ask about any part of the document to get insights, explanations, or key details.